期刊文献+

遗传性卵磷脂胆固醇酰基转移酶缺乏症肾损害 被引量:2

Renal disease associated with familiar lecithin-cholesterol acyltransferase deficiency
在线阅读 下载PDF
导出
摘要 中年女性患者,尿检异常2月,肾功能正常、轻度贫血,高密度脂蛋白胆固醇显著降低。患者及其二哥有鱼眼状角膜混浊。血卵磷脂胆固醇酰基转移酶(LCAT)活性明显降低。肾活检组织学肾小球基膜及系膜区广泛空泡变性,电镜下肾小球基膜及系膜区亦见广泛空泡化,少数空泡残留嗜锇性物质。访患者最终诊断为遗传性LCAT缺乏症肾损害。 A forty year-old woman presented with proteinuria and hematuria for two months. She had mild anemia, normal renal function and significantly lower high-density lipoprotein (HDL) cholesterol. Corneal greyish opacities were observed in the patient and her brother. The absence of LCAT activity was detected in this patient. Renal biopsy showed irregular thickening of the GBM and expansion of mesangial region with focal vacuolization. Electron microscopy showed glomerular epimembranous, intramembranous, subendothelial, and mesangial accumulations of extracellular lipid material with membranous profiles and granules. The final diagnosis was renal disease associated with familiar LCAT deficiency.
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2014年第3期283-288,共6页 Chinese Journal of Nephrology,Dialysis & Transplantation
关键词 卵磷脂胆固醇酰基转移酶缺乏症 鱼眼病 高密度脂蛋白胆固醇 lecithin-cholesterol acyltransferase deficiency fish-eye disease high-density lipoprotein
  • 相关文献

参考文献30

  • 1Kuivenhoven JA, Pritchard H, Hill J, et al.The molecular pathology of lecithin : cholesterol acyhransferase ( LCAT ) deficiency syndromes. J Lipid Res, 1997,38 (2) : 191-205.
  • 2Shoji K, Morita H, Ishigaki Y, et al. Lecithin-cholesterol acyltransferase (LCAT) deficiency without mutations in the coding sequence : a case report and literature review. Clin Nephrol, 2011,76 (4) :323-328.
  • 3Li M, Kuivenhoven JA, Ayyobi AF, et al. T→ G or T→A mutation introduced in the branchpoint consensus sequence of intron 4 of lecithin : cholesterol aeyltransferase ( LCAT ) gene : intron retention causing LCAT deficiency. Biochim Biophys Acta, 1998, 1391 (2) :256-264.
  • 4Frase~t GM,Soverini L, Tampieri E, et al.A 33-year-old man with nephrotie syndrome and lecithin-cholesterol aeyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene. Nephrol Dial Transplant,2004,19(6) : 1622-1624.
  • 5Gjone E, Blomhoff JP, Skarbovik AJ. Possible association between an abnormal low density lipoprotein and nephropathy in lecithin: cholesterol aeyltransferase deficieney.Cliniea Chimica Aeta, 1974,54 (1) :11-8.
  • 6Guefin M, Dachet C, Goulinet S, et al. Familial lecithin : cholesterol aeyltransferase deficiency: molecular analysis of a compound heterozygote : LCAT ( Arg<sup> 147</sup>→Trp) and LCAT ( Tyr< sup> 171 </sup>→Stop).Atberosclerosis, 1997,131 ( 1 ) : 85 -95.
  • 7Takahashi S, Hiromura K, Tsukida M, et al. Nephrotie syndrome caused by immune-mediated acquired LCAT deficiency. J Am Soc Nephrol,2013,24(8) : 1305-1312.
  • 8Simonelli S, Gianazza E, Mombelli G, et al. Severe high-density lipoprotein deficiency associated with autoantibodies against lecithin: cholesterol acyltransferase in non-Hodgkin lymphoma. Arch Intern Med,2012,172(2) : 179-181.
  • 9Vaziri ND, Liang K, Parks JS. Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome.Am J Physiol Renal Physiol, 2001,280( 5 ) : F823-828.
  • 10张小瑛,崔若兰,李霖,李闻捷.改良的LCAT测定及其在肾脏疾病中的临床意义[J].肾脏病与透析肾移植杂志,1995,4(4):318-319. 被引量:4

二级参考文献2

  • 1陈惠萍,曾彩虹,朱茂艳.Fabry病[J].肾脏病与透析肾移植杂志,1997,6(3):285-288. 被引量:12
  • 2彭腾,刘秉文.人血浆LCAT活力测定方法的探讨——自身底物法[J]生物化学与生物物理进展,1988(02).

共引文献10

同被引文献11

  • 1Qu Sl, Fan HZ, Blanco - Vaca F, et al. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase[l]. 1 Lipid Res, 1995,36(5): 967-974.
  • 2Funke H, von Eckardstein A, Pritchard PH, et al. Genetic and phenotypic heterogeneity in familial lecithin: cholesterol acyltransferase (LCAT) deficiency. Six newly identified defective alleles further contribute to the structural heterogeneity in this disease[J]. J Clin Invest, 1993,91(2): 677-683.
  • 3Idzior- Walus B. Familial LCAT deficiency[l]. Przegl Lek, 2001, 58(10): 919-923.
  • 4Scarpioni R, Paties C, Bergonzi G. Dramatic atherosclerotic vascular burden in a patient with familial lecithin - cholesterol acyltransferase (LCAT) deficiency [J]. Nephrol Dial Transplant, 2008, 23(3): 1074-1075 .
  • 51ahanzad I, Amoueian S, Attaranzadeh A. Familial lecithincholesterol acyltransferase deficiency[J]. Arch Iran Med, 2009,12 (2): 179-181.
  • 6Lager DJ, Rosenberg BF, Shapiro H, et al. Lecithin cholesterol acyltransferase deficiency: ultrastructural examination of sequential renal biopsies[J]. Mod Pathol, 1991,4(3): 331-335.
  • 7Takahashi S, Hiromura K, Tsukida M, et al. Nephrotic syndrome caused by immune - mediated acquired LCAT deficieney[l]. 1 Am Soc Nephrol, 2013, 24(8): 1305-1312.
  • 8Strem EH, Sund S, Reier-Nilsen M, et al. Lecithin: Cholesterol Acyltransferase (LeA T) Deficiency: renal lesions with early graft recurrence[J]. Ultrastruct Pathol, 2011, 35(3): 139-145.
  • 9Stockenbroek RM, van den Bergh Weerman MA, Hovingh GK, et al. Familial LCAT deficiency: from renal replacement to enzyme replacement [J]. Neth J Med, 2013, 71(1): 29-31.
  • 10陈霓,余英豪,曲利娟,曾德华.卵磷脂-胆固醇酰基转移酶缺乏肾病1例[J].临床与实验病理学杂志,2011,27(6):675-676. 被引量:1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部